Green Laura C, Crouch Edmund A C, Ames Michael R, Lash Timothy L
Cambridge Environmental, Massachusetts 02141, USA.
Regul Toxicol Pharmacol. 2002 Jun;35(3):327-37. doi: 10.1006/rtph.2002.1548.
Associations between airborne concentrations of fine particulate matter (PM(2.5)) and mortality rates have been investigated primarily by ecologic or semiecologic epidemiology studies. Many investigators and regulatory agencies have inferred that the weak, positive association often observed is causal, that it applies to all forms of airborne PM(2.5), and that current ambient levels of PM(2.5) require reduction. Before implementing stringent regulations of ambient PM(2.5), analysts should pause to consider whether the accumulated evidence is sufficient, and sufficiently detailed, to support the PM(2.5) National Ambient Air Quality Standard. We take two tacks. First, we analyze the toxicologic evidence, finding it inconsistent with the notion that current ambient concentrations of all forms of fine particulate matter should affect pulmonary, cardiac, or all-cause mortality rates. More generally, we note that the thousands of forms of PM(2.5) are remarkably diverse, yet the PM(2.5) NAAQS presumes them to be identical toxicologically, and presumes that reducing ambient concentrations of any form of PM(2.5) will improve public health. Second, we examine the epidemiologic evidence in light of two related examples of semiecologic associations, examples that both inform the PM-mortality association and have been called into question by individual-level data. Taken together, the toxicologic evidence and lessons learned from analogous epidemiologic associations should encourage further investigation of the association between particulate matter and mortality rates before additional regulation is implemented, and certainly before the association is characterized as causal and applicable to all PM(2.5).
空气中细颗粒物(PM2.5)浓度与死亡率之间的关联主要通过生态学或半生态学流行病学研究进行了调查。许多研究人员和监管机构推断,经常观察到的微弱正相关是因果关系,它适用于所有形式的空气中PM2.5,并且当前环境中的PM2.5水平需要降低。在实施严格的环境PM2.5法规之前,分析人员应停下来考虑积累的证据是否充分且足够详细,以支持PM2.5国家环境空气质量标准。我们采取两条途径。首先,我们分析毒理学证据,发现它与当前环境中所有形式的细颗粒物浓度应影响肺部、心脏或全因死亡率的观点不一致。更普遍地说,我们注意到PM2.5的数千种形式差异显著,但PM2.5国家环境空气质量标准假定它们在毒理学上是相同的,并假定降低任何形式的PM2.5环境浓度都将改善公众健康。其次,我们根据两个相关的半生态学关联示例来审视流行病学证据,这两个示例既为PM与死亡率的关联提供了信息,又受到个体层面数据的质疑。综合起来,毒理学证据以及从类似流行病学关联中吸取的教训应鼓励在实施进一步监管之前,当然在将该关联定性为因果关系并适用于所有PM2.5之前,进一步调查颗粒物与死亡率之间的关联。